Novo Nordisk Shares Are Trading Lower After the Company Sopped Its Ocedurenone Clarion-CKD Trial.
Novo Nordisk Shares Are Trading Lower After the Company Sopped Its Ocedurenone Clarion-CKD Trial.
諾和諾德股票因公司停止其Ocedurenone Clarion-CKD試驗而下跌交易。
Novo Nordisk Shares Are Trading Lower After the Company Sopped Its Ocedurenone Clarion-CKD Trial.
諾和諾德股票因公司停止其Ocedurenone Clarion-CKD試驗而下跌交易。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。